Isao Kawaguchi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Atopic Dermatitis

Top Venues

Journal of medical economics

Modern rheumatology

Advances in therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics 27 (1) (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics 27 (1) (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics 27 (1) (2024)
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang, Russell Miller
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of medical economics (2024)
Kei Ikeda, Yuko Kaneko, Yuki Tsujita, Isao Kawaguchi, Jayeshkumar Patel, Toru Yamazaki, Siran Fang, Yutaka Kawahito
Healthcare resource utilisation and economic burden of patients with adequate and inadequate responses to biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis in Japan. Modern rheumatology (2023)
Tatsuya Atsumi, Eri Asakura, Michio Doi, Ruta Sawant, Isao Kawaguchi, Nobuhito Sasaki, Danny Liew
Number Needed to Treat and Cost Per Responder of Janus Kinase Inhibitors Approved for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Japan. Modern rheumatology (2022)
Hiroyuki Murota, Yuta Koike, Kanako Ishii, Brian M Calimlim, Maja Ludwikowska, Mondher Toumi, Isao Kawaguchi
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes. Journal of medical economics 24 (1) (2021)
Isao Kawaguchi, Kazuaki Chayama, Yuri Sanchez Gonzalez, Suchin Virabhak, Dominic Mitchell, Cammy Yuen, Hiromitsu Kumada
A Cost-Effectiveness Analysis of Glecaprevir/Pibrentasvir Versus Existing Direct-Acting Antivirals to Treat Chronic Hepatitis C in Japan. Advances in therapy 37 (1) (2019)